AstraZeneca PLC aims for $80 billion revenue by 2030 through strong growth in oncology, biopharmaceuticals, and rare diseases ...
Four years after winning an FDA approval for Koselugo to treat children with the rare disorder neurofibromatosis type 1 (NF1) ...
On the heels of releasing its latest financial statement, Vancouver-based biotechnology company Absci announced it has met its first milestone in its collaboration with pharmaceutical giant AstraZenec ...
AstraZeneca has paused its planned £450 million investment in the UK for vaccine R&D as it continues discussions with the ...
In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...
TEZSPIRE demonstrated a statistically significant and clinically meaningful reduction in nasal polyp size and reduced nasal congestion compared to placebo ...
Covid vaccines left Aussie mother-of-two Ellie Sutton in such agony she 'prayed for death' and has considered euthanasia.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback